A resolution supporting the designation of September 2026 as "National Ovarian Cancer Awareness Month".
The source supplies the latest action, but no lifecycle stage.
Latest action (24 Sep 2026): Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S5009-5010)
What this bill does
This Senate resolution expresses support for designating September 2026 as National Ovarian Cancer Awareness Month. It highlights the severity of ovarian cancer, noting it is a leading cause of cancer death for women in the U.S. and that many cases are diagnosed at advanced stages due to a lack of reliable early detection methods and vague symptoms. The resolution also points out disparities in care and outcomes for certain groups of women.
The resolution would affect women in the United States by drawing public and potentially policy attention to ovarian cancer. It aims to increase awareness of the disease's symptoms, risks, and the importance of early detection and treatment. The bill is a resolution, meaning it does not create new laws or funding.
This resolution was introduced in the Senate on September 24, 2026, by Senator Elissa Slotkin. It has been referred to the Committee on Health, Education, Labor, and Pensions. The next step would be for the committee to consider the resolution.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
24 Sep 2026
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S5009-5010)
Common questions
- What does S.Res. 907 do?
- This Senate resolution expresses support for designating September 2026 as National Ovarian Cancer Awareness Month. It highlights the severity of ovarian cancer, noting it is a leading cause of cancer death for women in the U.S. and that many cases are diagnosed at advanced stages due to a lack of reliable early detection methods and vague symptoms. The resolution also points out disparities in care and outcomes for certain groups of women. The resolution would affect women in the United States by drawing public and potentially policy attention to ovarian cancer. It aims to increase awareness of the disease's symptoms, risks, and the importance of early detection and treatment. The bill is a resolution, meaning it does not create new laws or funding. This resolution was introduced in the Senate on September 24, 2026, by Senator Elissa Slotkin. It has been referred to the Committee on Health, Education, Labor, and Pensions. The next step would be for the committee to consider the resolution.
- Has S.Res. 907 become law?
- The source does not supply a confirmed lifecycle stage for S.Res. 907. Check the latest action and official source below.
- Who sponsored S.Res. 907?
- S.Res. 907 was sponsored by Sen. Slotkin, Elissa [D-MI] (D-MI), with 1 cosponsor.
- What's the latest action on S.Res. 907?
- Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S5009-5010) (24 Sep 2026).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Silicosis Prevention and Treatment Act
Access to Medical Supplies Act
More bills from Sen. Slotkin, Elissa [D-MI]
Ovarian Cancer IMPACT Act
A bill to require the Secretary of the Army to submit a report on efforts to support the production, testing, and sustainment of autonomous maneuver systems, components for such systems, and low-cost interceptors.
A bill to require a report on the advisability and feasibility of establishing a Drone Center of Excellence within the Army National Guard.
Military Leadership Removal Transparency Act of 2026
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.